Market Summary | Major Indices | Market Movers | Market Sectors | Mutual Funds | A-Z Stock Listings
ETF Screener | World Markets | Currencies | CEO Wealthmeter | Oil / Energy | Metals
Treasury Rates | Calculators | My Watchlist | My Portfolio
         Symbol Lookup
MIDDLEBROOK PHARMA Add to My Watchlist (NSDQ: MBRK) 
Detailed Quote
News
Chart
SEC Filings
Profile
Historical
Options
     MiddleBrook 0.42 -0.00 (-0.24%) 179,334
7 Village Circle
Suite 100
Westlae, TX 76262 US
(817) 837-1200
(817) 582-0400 fax
www.middlebrookpharma.com
CEO John S. Thievon
Auditor PRICEWATERHOUSECOOPERS LLP
Exchange Traded NQ
ISIN Number US5960871060
CIK Number 1161924
NAICS Code 325412
Business Summary
A pharmaceutical company focused on developing and commercializing anti-infective drug products that fulfill unmet medical needs.
Number of Employees 352
Share Fundamentals
Market Cap 36.33M
Shares Outstanding 86.51M
Float 55.60M
Short Interest 6.43M
Financial Strength
Revenue (TTM) $13,897,271
Earnings (TTM) -$58,164,787
Quick Ratio 2.5:1
Current Ratio 3:1
Total Debt/Equity 0:1
Profitability
Gross Margin N/A
EBITDA Margin N/A
Profit Margin N/A
Powered By: FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes.
All other data is delayed at least 20 minutes.
By accessing this page, you agree to the following terms and conditions.
Stock Updates provided by MarketMinute.com
Stock Analysis provided by SocialPicks Conference calls info supplied by OpenCompany
Fundamental data supplied by Mergent, Inc.
Stock quote data supplied by Telekurs